The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.
News|Videos|March 30, 2026
Q1 2026 recap: Top videos in pediatric care
Author(s)Celeste Krewson, Assistant Editor
Fact checked by: Yasmeen Qahwash
As we step into Q2 2026, take a look back at our top video interviews and packages of Q1.
Advertisement
Advertisement
Throughout the first quarter of 2026, our coverage at Contemporary Pediatrics has highlighted a broad spectrum of critical updates and emerging research across diverse therapeutic areas. Key focal points include evaluating demographic disparities in oral food challenge completion rates, assessing the safety and efficacy profile of tapinarof cream in pediatric atopic dermatitis, and examining the clinical implications of the newly updated US Dietary Guidelines.
Related to this article
A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.
In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
The FDA accepted the Anaphylm NDA resubmission as a class 2 response, setting a March 16, 2027, PDUFA date for the sublingual epinephrine film.
Nationwide Children's experts urge early screening and family-based lifestyle change as youth-onset T2D progresses faster than adult disease.
Maternal high egg and peanut intake in pregnancy and lactation did not lower infant IgE-mediated egg or peanut allergy at 1 year in PrEggNut.
Advertisement
Advertisement